The Application Effect of Endoscopic Thyroidectomy via the Gasless Unilateral Axillary Approach in Thyroid Cancer and Its Impact on Postoperative Stress Response
Abstract
:1. Introduction
2. Materials and Methods
2.1. Ethics Statement
2.2. General Data
2.3. Inclusion Criteria
2.4. Exclusion Criteria
2.5. Methods
- (1)
- The open group (conventional-open-anterior-cervical-approach thyroidectomy): the patients underwent general anaesthesia with tracheal intubation, and were placed in a supine position with their upper limbs abducted. Routine disinfection and draping were conducted. An arc-shaped incision was made along the skin creases at the level of the clavicle. The flap was carefully dissected from top to bottom, and the linea alba cervicalis was incised to fully expose the thyroid gland. The upper, middle, and lower thyroid blood vessels were managed, and the recurrent laryngeal nerves as well as any suspicious parathyroid tissue were identified and protected. The thyroid lobes and isthmus were resected, and lymph nodes in the central region were excised. Following the resection, the area was irrigated, hemostasis was achieved, and layer-by-layer suturing was performed, with drainage placement to complete the procedure.
- (2)
- The endoscopic group (GUA endoscopic thyroidectomy): the patients received general anaesthesia with tracheal intubation and were positioned supine with their upper limbs abducted. Routine disinfection and draping were conducted. A 4 cm incision was made in the axillary fold on the affected side, extending toward the sternum along the space between the sternal and clavicular heads of the sternocleidomastoid muscle. The sternal head of the muscle was elevated using a retractor, and the outer edge of the anterior cervical banded muscle was separated to expose the thyroid lobe. A suspension system was utilized to create the surgical cavity. The upper and lower poles of the thyroid arteries and veins were cauterized with an ultrasound knife, and the upper parathyroid glands were retained by the decapitation method. Special care was taken to protect the recurrent laryngeal nerves throughout the procedure. After the thyroid lobes and isthmus were removed and central lymph node dissection was completed, the surgical area was irrigated, hemostasis was achieved, and layer-by-layer suturing was performed, followed by drainage placement.
2.6. Observation Indicators
- (1)
- Perioperative indicators are as follows: intraoperative blood loss, postoperative drainage, number of lymph node dissection in the central region, pain degree 1 day postoperatively (assessed using the visual analogue scale (VAS), ranging from 0 for no pain to 10 for severe pain) [15]), surgical time, and hospitalization time.
- (2)
- Thyroid function: Before and 2 days after surgery, 3 mL of fasting elbow vein blood was collected from patients in both groups. The blood was centrifuged at 3000 r/min for 10 min with a rotor radius of 5 cm, and the serum was separated. The levels of total triiodothyronine (TT3), total tetraiodothyronine (TT4), free triiodothyronine (FT3), free tetraiodothyronine (FT4), and thyroid-stimulating hormone (TSH) were tested using a fully automated biochemical analyzer (iChem 520; Shenzhen Icubio Biomedical Technology Co., Ltd., Shenzhen, China).
- (3)
- Inflammatory factors: Before surgery and 1 day after surgery, 3 mL of fasting elbow venous blood was collected and centrifuged as described above. Serum levels of interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) were assessed by enzyme-linked immunosorbent assay (ELISA) using kits purchased from eBioscience (San Diego, CA, USA).
- (4)
- Stress response indicators: Prior to surgery and 1 day after surgery, 3 mL of fasting elbow vein blood was collected and processed as described above. The serum levels of norepinephrine (NE) and cortisol (Cor) were measured by ELISA, with kits from eBioscience (San Diego, CA, USA).
- (5)
- Incision aesthetics: The incision aesthetics was assessed by the Vancouver Scar Scale (VSS) at 1 and 3 months postoperatively. The VSS assesses 4 aspects: colour, vascular distribution, thickness, and softness, with a total score of 0–15 points. Lower scores correspond to better aesthetic outcomes.
- (6)
- Postoperative complications: Patients were followed up for 3 months after surgery. The complications assessed included temporary recurrent laryngeal nerve paralysis, parathyroid gland injury, incision infection, and hypocalcaemia.
2.7. Statistics
3. Results
3.1. Baseline Characteristic
3.2. Perioperative Indicators
3.3. Thyroid Function
3.4. Inflammatory Factors
3.5. Stress Response
3.6. Incision Aesthetics
3.7. Postoperative Complications
4. Discussion
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Dhuli, K.; Medori, M.C.; Donato, K.; Donato, K.; Maltese, P.E.; Tanzi, B.; Tezzele, S.; Mareso, C.; Miertus, J.; Generali, D.; et al. Omics sciences and precision medicine in thyroid cancer. Clin. Ter. 2023, 174, 11–20. [Google Scholar] [CrossRef]
- Wu, Z.; Han, L.; Li, W.; Wang, W.; Chen, L.; Yao, Y.; Wang, Y. Which is preferred for initial treatment of papillary thyroid cancer, total thyroidectomy or lobotomy? Cancer Med. 2021, 10, 1614–1622. [Google Scholar] [CrossRef]
- Pinheiro Neto, A.; Lucchesi, H.L.; Valsecchi, V.; Ward, L.S.; Cunha, L.L. Immunotherapy for patients with thyroid cancer: A comprehensive appraisal. Chin. Clin. Oncol. 2024, 13, 36. [Google Scholar] [CrossRef]
- Kaczmarzyk, I.; Nowak-Perlak, M.; Wozniak, M. Promising Approaches in Plant-Based Therapies for Thyroid Cancer: An Overview of In Vitro, In Vivo, and Clinical Trial Studies. Int. J. Mol. Sci. 2024, 25, 4463. [Google Scholar] [CrossRef]
- Pishdad, R.; Treglia, G.; Mehta, A.; Santhanam, P. Somatostatin receptor imaging of thyroid tissue and differentiated thyroid cancer using gallium-68-labeled radiotracers-a review of clinical studies. Endocrine 2024, 85, 566–575. [Google Scholar] [CrossRef] [PubMed]
- Chen, Y.H.; Chao, W.P.; Wang, S.H.; Huang, Y.T.; Ng, S.C. Transoral endoscopic and robotic thyroidectomy for thyroid cancer: The mid-term oncological outcome. Surg. Endosc. 2023, 37, 7829–7838. [Google Scholar] [CrossRef]
- Yang, Y.; Gu, X.; Wang, X.; Xiang, J.; Chen, Z. Endoscopic thyroidectomy for differentiated thyroid cancer. Sci. World J. 2012, 2012, 456807. [Google Scholar] [CrossRef]
- Wang, G.; Zhang, G.; Gao, X. Clinical effect of Lymph Node Dissection in the Lateral Neck for the treatment of Papillary Thyroid Carcinoma: Endoscopic Thyroidectomy versus Open Surgery. Pak. J. Med. Sci. 2023, 39, 1680–1684. [Google Scholar] [CrossRef]
- Chang, S.; Tang, H.H.; Wang, C.C.; Zhou, L.D.; Li, J.D.; Huang, Y.; Zeng, Q.J.; Wang, Z.M. A standard approach to expose the recurrent laryngeal nerve during endoscopic thyroidectomy. J. Laparoendosc. Adv. Surg. Tech. Part A 2012, 22, 259–263. [Google Scholar] [CrossRef]
- Li, X.; Ding, W.; Zhang, H. Surgical outcomes of endoscopic thyroidectomy approaches for thyroid cancer: A systematic review and network meta-analysis. Front. Endocrinol. 2023, 14, 1256209. [Google Scholar] [CrossRef]
- Ge, J.N.; Yu, S.T.; Sun, B.H.; Wei, Z.G.; Zhang, Z.C.; Chen, W.S.; Li, T.T.; Lei, S.T. A novel anatomy-based five-settlement method for endoscopic thyroid lobectomy and ipsilateral central compartment neck dissection via gasless unilateral axillary approach: A preliminary report. Front. Endocrinol. 2023, 14, 1147313. [Google Scholar] [CrossRef] [PubMed]
- Sung, E.S.; Ji, Y.B.; Song, C.M.; Yun, B.R.; Chung, W.S.; Tae, K. Robotic Thyroidectomy: Comparison of a Postauricular Facelift Approach with a Gasless Unilateral Axillary Approach. Otolaryngol. Head Neck Surg. Off. J. Am. Acad. Otolaryngol. Head Neck Surg. 2016, 154, 997–1004. [Google Scholar] [CrossRef] [PubMed]
- Hu, X.; Xin, Y.; Zheng, C.; Meng, K.; Ge, M. “Three-propulsion” suspension method for endoscopic thyroid surgery gasless axillary approach. Zhejiang Da Xue Xue Bao. Yi Xue Ban J. Zhejiang Univ. Med. Sci. 2021, 50, 694–700. [Google Scholar] [CrossRef]
- Jarzab, B.; Dedecjus, M.; Slowinska-Klencka, D.; Lewinski, A.; Adamczewski, Z.; Anielski, R.; Baglaj, M.; Baldys-Waligorska, A.; Barczynski, M.; Bednarczuk, T.; et al. Guidelines of Polish National Societies Diagnostics and Treatment of Thyroid Carcinoma. 2018 Update. Endokrynol. Pol. 2018, 69, 34–74. [Google Scholar] [CrossRef]
- Faiz, K.W. VAS—visual analog scale. Tidsskr. Den Nor. Laegeforening Tidsskr. Prakt. Med. Ny Raekke 2014, 134, 323. [Google Scholar] [CrossRef]
- Singh, N.K.; Hage, N.; Ramamourthy, B.; Nagaraju, S.; Kappagantu, K.M. Nuclear Imaging Modalities in the Diagnosis and Management of Thyroid Cancer. Curr. Mol. Med. 2024, 24, 1091–1096. [Google Scholar] [CrossRef]
- Lukasiewicz, M.; Zwara, A.; Kowalski, J.; Mika, A.; Hellmann, A. The Role of Lipid Metabolism Disorders in the Development of Thyroid Cancer. Int. J. Mol. Sci. 2024, 25, 7129. [Google Scholar] [CrossRef]
- Jongekkasit, I.; Jitpratoom, P.; Sasanakietkul, T.; Anuwong, A. Transoral Endoscopic Thyroidectomy for Thyroid Cancer. Endocrinol. Metab. Clin. N. Am. 2019, 48, 165–180. [Google Scholar] [CrossRef]
- Wang, H.; Liu, R.; Zhang, C.; Fang, Q.; Zeng, Z.; Wang, W.; You, S.; Fang, M.; Dingtian, J. Modification and application of “zero-line” incision design in total endoscopic gasless unilateral axillary approach thyroidectomy: A preliminary report. Front. Surg. 2023, 10, 1121292. [Google Scholar] [CrossRef]
- Xu, S.; Wang, P.; Miao, B.; Xu, T.; Zhang, Y.; Wang, J.; Chen, S. Endoscopic thyroidectomy using gasless axillary approach for low-risk papillary thyroid carcinoma. Zhejiang Da Xue Xue Bao. Yi Xue Ban J. Zhejiang University. Med. Sci. 2021, 50, 716–721. [Google Scholar] [CrossRef]
- Crippa, J.; Mari, G.M.; Miranda, A.; Costanzi, A.T.; Maggioni, D. Surgical Stress Response and Enhanced Recovery after Laparoscopic Surgery—A systematic review. Chirurgia 2018, 113, 455–463. [Google Scholar] [CrossRef] [PubMed]
- Ji, Y.B.; Song, C.M.; Bang, H.S.; Lee, S.H.; Park, Y.S.; Tae, K. Long-term cosmetic outcomes after robotic/endoscopic thyroidectomy by a gasless unilateral axillo-breast or axillary approach. J. Laparoendosc. Adv. Surg. Tech. Part A 2014, 24, 248–253. [Google Scholar] [CrossRef] [PubMed]
- Xu, J.J.; Zhang, L.Z.; Zhang, Q.H.; Guo, H.W.; Tan, Z.; Wang, J.F.; Jiang, L.H.; Zheng, C.M.; Ge, M.H.; Lan, X.B. Clinical application of the gasless unilateral axillary approach in endoscopic thyroid surgery. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi Chin. J. Otorhinolaryngol. Head Neck Surg. 2020, 55, 913–920. [Google Scholar] [CrossRef]
Indicators | The Endoscopic Group (n = 47) | The Open Group (n = 47) | χ2 | p |
---|---|---|---|---|
Gender | 0.237 | 0.626 | ||
Male | 12 (25.53) | 10 (21.28) | - | - |
Female | 35 (74.47) | 37 (78.72) | - | - |
Age | 0.783 | 0.376 | ||
18–40 years old | 17 (36.17) | 13 (27.66) | - | - |
41–60 years old | 30 (63.83) | 34 (72.34) | - | - |
Maximum tumor Diameter | 1.659 | 0.198 | ||
≤10 mm | 14 (29.79) | 20 (42.55) | - | - |
>10 mm | 33 (70.21) | 27 (57.45) | - | - |
Tumor location | 0.170 | 0.680 | ||
Left lobe | 24 (51.06) | 22 (46.81) | - | - |
Right lobe | 23 (48.94) | 25 (53.19) | - | - |
Number of tumors | 0.384 | 0.536 | ||
Single | 26 (55.32) | 23 (48.94) | - | - |
Multiple | 21 (44.68) | 24 (51.06) | - | - |
Pathological type | 0.714 | 0.398 | ||
Papillary carcinoma | 41 (87.23) | 38 (80.85) | - | - |
Follicular carcinomas | 6 (12.77) | 9 (19.15) | - | - |
TNM staging | 0.389 | 0.533 | ||
I stage | 19 (40.43) | 22 (46.81) | - | - |
II stage | 28 (59.57) | 25 (53.19) | - | - |
Indicators | The Endoscopic Group (n = 47) | The Open Group (n = 47) | Z/t | p |
---|---|---|---|---|
Intraoperative blood loss (mL) | 20.00 (17.00, 22.00) | 31.00 (29.00, 34.00) | −8.320 | <0.001 |
Postoperative drainage (mL) | 77.98 ± 9.93 | 127.21 ± 9.40 | −24.676 | <0.001 |
Number of lymph node dissection in the central region (numbers) | 3.00 (3.00, 3.00) | 3.00 (2.00, 3.00) | −0.941 | 0.347 |
Pain degree 1 day postoperatively (points) | 4.00 (3.00, 4.00) | 6.00 (5.00, 6.00) | −7.839 | <0.001 |
Surgical time (min) | 122.98 ± 8.18 | 81.98 ± 9.93 | 21.848 | <0.001 |
Hospitalization time (d) | 5.00 (5.00, 6.00) | 7.00 (6.00, 7.00) | −5.532 | <0.001 |
Time | The Endoscopic Group (n = 47) | The Open Group (n = 47) | t | p |
---|---|---|---|---|
Preoperatively | ||||
TT3 (pg/mL) | 1.84 ± 0.28 | 1.86 ± 0.30 | −0.346 | 0.730 |
TT4 (pg/mL) | 104.72 ± 8.44 | 103.84 ± 8.63 | 0.500 | 0.619 |
FT3 (pg/L) | 4.67 ± 0.45 | 4.72 ± 0.47 | −0.536 | 0.594 |
FT4 (pg/L) | 16.28 ± 1.37 | 16.15 ± 1.47 | 0.442 | 0.659 |
TSH (mU/L) | 2.50 ± 0.30 | 2.48 ± 0.27 | 0.350 | 0.727 |
2 days postoperatively | ||||
TT3 (pg/mL) | 1.12 ± 0.30 a | 1.03 ± 0.20 a | 1.772 | 0.080 |
TT4 (pg/mL) | 75.39 ± 5.20 a | 73.96 ± 5.48 a | 1.299 | 0.197 |
FT3 (pg/L) | 2.70 ± 0.33 a | 2.64 ± 0.28 a | 1.005 | 0.317 |
FT4 (pg/L) | 11.74 ± 1.40 a | 11.41 ± 1.00 a | 1.314 | 0.192 |
TSH (mU/L) | 4.32 ± 0.38 a | 4.21 ± 0.44 a | 1.306 | 0.195 |
Time | The Endoscopic Group (n = 47) | The Open Group (n = 47) | t | p |
---|---|---|---|---|
Preoperatively | ||||
IL-6 (pg/mL) | 0.20 ± 0.06 | 0.22 ± 0.09 | 1.268 | 0.208 |
TNF-α (pg/mL) | 0.66 ± 0.15 | 0.70 ± 0.29 | 1.050 | 0.297 |
1 day postoperatively | ||||
IL-6 (pg/mL) | 2.70 ± 0.72 a | 2.98 ± 1.04 a | 3.594 | 0.001 |
TNF-α (pg/mL) | 5.02 ± 1.57 a | 6.24 ± 1.69 a | 3.626 | 0.001 |
Time | The Endoscopic Group (n = 47) | The Open Group (n = 47) | t | p |
---|---|---|---|---|
Preoperatively | ||||
Cor (mmol/L) | 118.86 ± 9.76 | 117.71 ± 11.18 | 0.533 | 0.596 |
NE (pg/mL) | 515.15 ± 24.46 | 516.94 ± 33.16 | −0.297 | 0.767 |
1 day postoperatively | ||||
Cor (mmol/L) | 123.21 ± 6.44 a | 138.84 ± 7.80 a | −10.594 | <0.001 |
NE (pg/mL) | 527.62 ± 34.44 a | 656.79 ± 34.33 a | −18.210 | <0.001 |
Time | The Endoscopic Group (n = 47) | The Open Group (n = 47) | Z | p |
---|---|---|---|---|
VSS at 1 month postoperatively | 5.00 (4.00, 6.00) | 7.00 (6.00, 7.00) | −6.820 | <0.001 |
VSS at 3 months postoperatively | 4.00 (3.00, 4.00) | 5.00 (4.00, 6.00) | −5.774 | <0.001 |
Complications | The Endoscopic Group (n = 47) | The Open Group (n = 47) | χ2 | p |
---|---|---|---|---|
Temporary recurrent laryngeal nerve paralysis | 2 (4.26) | 1 (2.13) | - | - |
Parathyroid gland injury | 1 (2.13) | 3 (6.38) | - | - |
Incision infection | 0 (0.00) | 1 (2.13) | - | - |
Hypocalcaemia | 0 (0.00) | 1 (2.13) | - | - |
Total | 3 (6.38) | 6 (12.77) | 1.106 | 0.486 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Jia, J.; Han, J.; Pang, R.; Bi, W.; Liu, B.; Sheng, R.; Kong, L. The Application Effect of Endoscopic Thyroidectomy via the Gasless Unilateral Axillary Approach in Thyroid Cancer and Its Impact on Postoperative Stress Response. Curr. Oncol. 2025, 32, 252. https://doi.org/10.3390/curroncol32050252
Jia J, Han J, Pang R, Bi W, Liu B, Sheng R, Kong L. The Application Effect of Endoscopic Thyroidectomy via the Gasless Unilateral Axillary Approach in Thyroid Cancer and Its Impact on Postoperative Stress Response. Current Oncology. 2025; 32(5):252. https://doi.org/10.3390/curroncol32050252
Chicago/Turabian StyleJia, Jinliang, Jihua Han, Rui Pang, Wen Bi, Bo Liu, Ruinan Sheng, and Lingyu Kong. 2025. "The Application Effect of Endoscopic Thyroidectomy via the Gasless Unilateral Axillary Approach in Thyroid Cancer and Its Impact on Postoperative Stress Response" Current Oncology 32, no. 5: 252. https://doi.org/10.3390/curroncol32050252
APA StyleJia, J., Han, J., Pang, R., Bi, W., Liu, B., Sheng, R., & Kong, L. (2025). The Application Effect of Endoscopic Thyroidectomy via the Gasless Unilateral Axillary Approach in Thyroid Cancer and Its Impact on Postoperative Stress Response. Current Oncology, 32(5), 252. https://doi.org/10.3390/curroncol32050252